AzTrials
AzTrials

Cesarean Section ScarNCT03182010

Ultrasound Evaluation of Cesarean Scar After Uterotomy Closure With Barbed and Conventional Sutures

A study testing Cesarean section incision closure using barbed sutures and Cesarean section incision closure using conventional sutures in people with Cesarean Section Scar, run by Cairo University at 1 site in Egypt.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The aim of this randomized control trial is to compare the residual myometrial thickness and the depth of cesarean section scar defect after uterine incision closure with barbed or conventional sutures. Read more about this study

Who is it for?
Ages 18 to 50 years, women only
Conditions the study is for
Cesarean Section Scar
What is being tested?
Cesarean section incision closure using barbed sutures and Cesarean section incision closure using conventional sutures
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
110 participants
Where
1 siteEgypt
Study dates
Aug 2017to Aug 2020
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 50 years
  • Women only
  • No healthy volunteers
  • Adult

Who may be able to join

  • Primigravida patients undergoing transverse lower segment cesarean section

Who cannot join

  • Previous laparotomies
  • Postoperative fever
  • Patients with preterm pregnancies or in labor

Trial locations and contacts

1 site in 1 country.

Usama M Fouda, Prof. contact

01095401375

umfrfouda@yahoo.com

Egypt1 site
  • Cairo university

    Cairo

Other trials in Egypt

About this study

Official title: Ultrasound Evaluation of Cesarean Scar After Uterotomy Closure With Barbed and Conventional Sutures ; a Randomized Controlled Study

The aim of this randomized control trial is to compare the residual myometrial thickness and the depth of cesarean section scar defect after uterine incision closure with barbed or conventional sutures.

Read the detailed description

The aim of this randomized control trial is to compare the residual myometrial thickness and the depth of cesarean section scar defect after uterine incision closure with barbed or conventional sutures. Primigravida patients undergoing transverse lower segment cesarean section will be included in the study.Cesarean section incision will be closed with double layers of continuous barbed or conventional sutures. Ultrasound examination will be performed 6 months after the operation to measure the residual myometrial thickness and the scar depth.

Being tested
Cesarean section incision closure using barbed sutures, Cesarean section incision closure using conventional sutures
Keywords
Cesarean section scar, Barbed suture, Conventional suture

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Cesarean section incision closure using barbed suturesDevice

    Cesarean section incision will be closed using a 24-cm × 24-cm 0 polydioxanone double-armed suture on a 26-mm half-circle reverse cutting needle( STRATAFIX™ Spiral PDO Knotless Tissue Control Device, Ethicon Inc , Somerville, NJ, USA ).Ultrasound examination will be performed 6 months after the operation to measure the residual myometrial thickness and the scar depth.

  • Cesarean section incision closure using conventional suturesDevice

    Cesarean section incision will be closed using 1-0 polyglactin 910 suture(VICRYL™.; Ethicon Inc, Sommerville, NJ) .Ultrasound examination will be performed 6 months after the operation to measure the residual myometrial thickness and the scar depth.

Study groups in NCT03182010
Study groupRoleWhat they receive
Cesarean section incision closure using barbed suturesExperimentalCesarean section incision is closed using barbed sutures
Receives: Device: Cesarean section incision closure using barbed sutures
Cesarean section incision closure using conventional suturesActive comparatorCesarean section incision is closed using conventional sutures
Receives: Device: Cesarean section incision closure using conventional sutures

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Residual myometrial thickness

    Thickness of myometrium under the niche

    Measured: Six months after cesarean section

Secondary outcomes (1)
  1. Scar depth

    Measured: Six months after cesarean section

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted9 Jun 2017
  2. Study startAug 2017 (estimated)
  3. Primary completionAug 2020 (estimated)
  4. Study completionAug 2020 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Diagnosis
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
110 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03182010
Sponsor's protocol ID
Barbed sutures/Cesarean scar
Status last verified
Jun 2017
First submitted
7 Jun 2017
Last updated
14 Jun 2017
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Cesarean section incision closure using barbed sutures and Cesarean section incision closure using conventional sutures in people with Cesarean Section Scar, run by Cairo University at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 14 Jun 2017. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Usama M Fouda, Prof. (01095401375, umfrfouda@yahoo.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Residual myometrial thickness (time frame: Six months after cesarean section). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 14 Jun 2017.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in